Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in patients with acute coronary syndromes undergoing coronary artery bypass grafting

JAMA Cardiology

Volumn 1, Issue 8, 2016, Pages 921-928

  Gherli, Riccardo ^a   Mariscalco, Giovanni ^b   Dalén, Magnus ^c   Onorati, Francesco ^d   Perrotti, Andrea ^e   Chocron, Sidney ^e   Verhoye, Jean Philippe ^f   Gulbins, Helmut ^g   Reichart, Daniel ^g   Svenarud, Peter ^c   Faggian, Giuseppe ^c   Santarpino, Giuseppe ^h   Fischlein, Theodor ^h   Maselli, Daniele ⁱ   Dominici, Carmelo ⁱ   Musumeci, Francesco ^a   Rubino, Antonino S ^j   Mignosa, Carmelo ^j   De Feo, Marisa ^k   Bancone, Ciro ^k   Gatti, Giuseppe ^l   Maschietto, Luca ^l   Santini, Francesco ^m   Nicolini, Francesco ⁿ   Gherli, Tiziano ⁿ   Zanobini, Marco ^o   Kinnunen, Eeva Maija ^p   Ruggieri, Vito G ^f   Rosato, Stefano ^q   Biancari, Fausto ^p   more..

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY HOSPITAL OF VERONA   (Italy)

^e UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^f PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^g UNIVERSITY HEART CENTER HAMBURG   (Germany)

^h Department of Urology   (Germany)

ⁱ S ANNA HOSPITAL   (Italy)

^j Centro Cuore Morgagni   (Italy)

^k SECOND UNIVERSITY OF NAPLES   (Italy)

^l OSPEDALI RIUNITI   (Italy)

^m UNIVERSITY OF GENOA   (Italy)

ⁿ UNIVERSITY OF PARMA   (Italy)

^o UNIVERSITY OF MILAN   (Italy)

^p OULU UNIVERSITY HOSPITAL   (Finland)

^q ISTITUTO SUPERIORE DI SANITÀ   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TICAGRELOR; ADENOSINE; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMBINATION DRUG THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG USE; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OPERATIVE BLOOD LOSS; PREOPERATIVE TREATMENT; PROSPECTIVE STUDY; THROMBOCYTE TRANSFUSION; THROMBOSIS; TREATMENT WITHDRAWAL; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; VERY ELDERLY;

ACUTE CORONARY SYNDROME; ADENOSINE; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES;

EID: 85010348405     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.3028     Document Type: Article

References (21)

1. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation [published corrections appear in N Engl J Med 2001;345(20):1506 and 2001;345(23):1716]. N Engl J Med. 2001;345(7):494-502.
2. Wiviott SD, Braunwald E, McCabe CH, et al; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes.NEngl J Med. 2007;357(20):2001-2015.
3. Wallentin L, Becker RC, Budaj A, et al; PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045-1057.
4. RoffiM, Patrono C, Collet JP, et al; Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267-315.
5. Windecker S, Kolh P, Alfonso F, et al; Authors/Task Force Members. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541-2619.
6. Anderson JL, Adams CD, Antman EM, et al. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in J AmColl Cardiol. 2013;62(11):1040-1041]. J Am Coll Cardiol. 2013; 61(23):e179-e347. doi:10.1016/j.jacc.2013.01.014.
7. Jneid H, Anderson JL,Wright RS, et al. 2012ACCF/AHAfocused update of the guideline for the management of patients with unstable angina/non-ST-elevationmyocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J AmColl Cardiol. 2012;60(7):645-681.
8. Held C, Asenblad N, Bassand JP, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J AmColl Cardiol. 2011; 57(6):672-684.
9. Capodanno D, Angiolillo DJ. Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation. 2013;128(25):2785-2798.
10. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124(23):2610-2642.
11. Ferraris VA, Saha SP, Oestreich JH, et al; Society of Thoracic Surgeons. 2012 Update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg. 2012;94(5):1761-1781.
12. Hansson EC, Rexius H, Dellborg M, Albertsson P, JeppssonA. Coronary artery bypass grafting-related bleeding complications in real-life acute coronary syndrome patients treated with clopidogrel or ticagrelor. Eur JCardiothorac Surg. 2014;46(4):699-705.
13. Smith PK, Goodnough LT, Levy JH, et al. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: risk-adjusted retrospective data analysis. J AmColl Cardiol. 2012;60(5):388-396.
14. Hansson EC, Jidéus L, Åberg B, et al. Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study. Eur Heart J. 2016;37(2):189-197.
15. Schotola H, BräuerA,Meyer K, et al. Perioperative outcomes of cardiac surgery patients with ongoing ticagrelor therapy: boon and bane of a new drug. Eur J Cardiothorac Surg. 2014;46(2):198-205.
16. Biancari F, Ruggieri VG, Perrotti A, et al. European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG registry): study protocol for a prospective clinical registry and proposal of classification of postoperative complications. J Cardiothorac Surg. 2015;10:90.
17. Mariscalco G, Gherli R,AhmedAB, et al.Validation of the European Multicenter Study on Coronary Artery Bypass Grafting (E-CABG) bleeding severity definition. Ann Thorac Surg. 2016;101(5):1782-1788.
18. Dyke C, Aronson S, DietrichW, et al. Universal Definition of Perioperative Bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg. 2014;147(5): 1458-1463.e1. doi:10.1016/j.jtcvs.2013.10.070.
19. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55.
20. Austin PC. Optimal caliper widths for propensityscore matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150-161.
21. Becker RC, Bassand JP, BudajA, et al. Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the Platelet Inhibition and Patient Outcomes (PLATO) trial [published correction appears in Eur Heart J. 2012;33(21):2750]. Eur Heart J. 2011;32(23):2933-2944.